NCT05332054

An Observational Long-Term Follow-up Study of Patients Who Received Prior Caribou Cell Therapy

Study Summary

This is an observational, non-interventional, LTFS of investigational Caribou therapies in patients who have participated in a parent study: a prior Caribou-sponsored clinical study, special access program, or an IIT. The objective is to evaluate the long-term safety, through 15 years post infusion, in patients who received IPs in a Caribou-sponsored clinical study, special access program or IIT.

Want to learn more about this trial?

Request More Info

Interventions

Caribou-sponsored investigational therapyBIOLOGICAL
N/A this is an observational study

Study Locations

FacilityCityStateCountry
University of AlabamaBirminghamAlabamaUnited States
Banner MD Anderson Cancer CenterGilbertArizonaUnited States
Honor Health Research InstituteScottsdaleArizonaUnited States
University of California IrvineIrvineCaliforniaUnited States
University of California San DiegoLa JollaCaliforniaUnited States
University of ColoradoDenverColoradoUnited States
Colorado Blood Cancer InstituteDenverColoradoUnited States
University of MiamiMiamiFloridaUnited States
AdventHealth Medical Group Blood & Marrow Transplant at OrlandoOrlandoFloridaUnited States
Blood & Marrow Transplant Group of GeorgiaAtlantaGeorgiaUnited States
Augusta University/Georgia Cancer CenterAugustaGeorgiaUnited States
University of Iowa Hospitals & ClinicsIowa CityIowaUnited States
University of KentuckyLexingtonKentuckyUnited States
Norton Cancer InstituteLouisvilleKentuckyUnited States
Regional Cancer Care Associates - HackensackHackensackNew JerseyUnited States
Atlantic Health System Cancer CareMorristownNew JerseyUnited States
Weill Cornell MedicineNew YorkNew YorkUnited States
Icahn School of Medicine at Mt. SinaiNew YorkNew YorkUnited States
Montefiore Medical CenterThe BronxNew YorkUnited States
Levine Cancer CenterCharlotteNorth CarolinaUnited States
Oncology Hematology CareCincinnatiOhioUnited States
Cleveland ClinicClevelandOhioUnited States
University of PennsylvaniaPhiladelphiaPennsylvaniaUnited States
Sarah Cannon Research Institute - TriStar HealthNashvilleTennesseeUnited States
University of Texas SouthwesternDallasTexasUnited States
Baylor Research InstituteDallasTexasUnited States
MD Anderson Cancer CenterHoustonTexasUnited States
Huntsman Cancer Institute at the University of UtahSalt Lake CityUtahUnited States
Virginia Commonwealth UniversityRichmondVirginiaUnited States
Fred Hutchinson Cancer CenterSeattleWashingtonUnited States
Medical College of WisconsinMilwaukeeWisconsinUnited States

Official Trial Information

View on ClinicalTrials.gov

Data sourced from ClinicalTrials.gov. Last updated: April 14, 2026